RENEW ENERGY GLOBAL PLC (RNW): what the price assumes

In the published model solve dated 2026-Q2, anchored at $6.11, RENEW ENERGY GLOBAL PLC (RNW) is priced for today's economics sustained for ~8.0 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/RNW

Headline

FieldValue
TickerRNW
CompanyRENEW ENERGY GLOBAL PLC
Current price$6.11/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Must persist for8.0y
Multiple paid81x operating income

Solve inputs: computed at a 7% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.6 years (computed at the 7% minimum rate; the CAPM rate 4.7% sits below it).

Reconcile: at the x-ray's 9.3% required return this reads ~13.4 years; the models below use their own rates.

How unusual the bet is: elevated (limited comparison data)

ReferenceValue
sustained it ~8 years at this level26%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset6.17x5expensive
Earnings1.46x3expensive
Relative1.30x4expensive
Growth0.48x2justifies

Families that justify the price: Growth Families that call it expensive: Asset

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.9%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
DCF Exit MultipleGrowth$36.030.17xyesExit EV/EBITDA: 23.4x / 25.4x / 27.4x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$4.471.37xyesP/E 26.32x (blended: static sector reference 20x + trailing (TTM) 41x), scenarios: 21.7x / 26.3x / 30.9x (bear / base = reference held flat / bull), EV/EBITDA 16.72x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$1.613.80xyesBV/sh $4.23, ROE (TTM) 3.5%, ke 9.3%
Two-Stage Excess ReturnAsset$0.996.17xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$7.670.80xyesRev $1.3B, growth 12% (input: historical growth; tapered), Terminal P/S: 1.4x / 1.7x / 2.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$4.551.34xyesEPS $0.13, growth 35% (input: historical EPS growth), PEG=1.17 (Fair)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$0.01611.00xyesNormalized EBIT (4y avg op income, one-time charges added back) $0.01B × (1−40%) / WACC 4.9% → EPV (no growth) (excluded from median)
Residual IncomeAsset$0.758.15xyesBV $4.23 + 5yr PV of (ROE (TTM) 3.5% − Kₑ 9.3%) × BV; BV grows 2.3%/yr
Graham NumberAsset$3.521.74xyes√(22.5 × EPS $0.13 × BVPS $4.23) — Graham's conservative floor
EV/EBITDA RelativeRelative$0.01611.00xyesEBITDA $0.36B × sector EV/EBITDA 13.0x (excluded from median)
FCF YieldEarnings$4.471.37xyesFCF $791.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$4.191.46xyesEPS $0.13 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$0.738.37xyesBV $4.23 × (ROIC 0.8% / WACC 4.9%)
P/Sales SectorRelative$8.800.69xyesRevenue $1.28B × sector P/S 2.5x
PEG Fair ValueRelative$4.881.25xyesEPS $0.13 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings YieldEarnings$1.414.33xyesEPS $0.13 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$7.2b
Net debt / NOPAT (after-tax)134.63x
Net debt / operating income (pre-tax)60.99x
Interest coverage0.2x
Burning cashno

Bullet Takeaways

Bull Case

The number that anchors the bull case is capacity, because for a renewable power producer installed gigawatts are the asset that compounds. ReNew's operating portfolio reached 12.8 GW, a 25 percent increase year over year, with 2.4 GW of new capacity commissioned in the most recent fiscal year. Each gigawatt comes with long-term power-purchase contracts that turn sunshine and wind into contracted, inflation-resistant cash flow for decades. A company adding capacity at a double-digit annual rate in a country with India's structural demand for power is building an annuity stream that the current accounting earnings, depressed by the heavy depreciation and interest that come with new assets, do not yet reflect.

The financial trajectory is bending the right way. Fiscal 2026 revenue grew 36 percent to roughly ₹132 billion, net income rose 162 percent to about ₹10 billion, and adjusted EBITDA, the measure that matters for a capital-intensive utility, grew 31 percent to roughly ₹75 billion, above the company's prior guidance. Crucially, leverage declined even as the fleet grew, and management raised its EBITDA outlook for the next fiscal year. Rising EBITDA with falling leverage is the combination that de-risks a debt-funded infrastructure builder: the cash flow that services and reduces the debt is growing faster than the debt itself.

The strategic move upstream adds a second growth lever. ReNew is building toward an additional 4 GW of solar-cell manufacturing capacity, which would let it capture more of the value chain and reduce dependence on imported components, a meaningful edge as India pushes domestic content in renewables. The valuation methods reflect a business priced well below the cash flow its assets can generate: the relative-multiple and forward-growth methods land at or above the price, and a free-cash-flow lens reads the stock as inexpensive relative to the cash the fleet throws off. For an investor who can underwrite the debt and the execution, a leading position in one of the world's largest renewable-energy build-outs, with EBITDA rising and leverage falling, is the growth-infrastructure bet the bull case rests on.

Bear Case

The plain truth a holder has to confront is how little accounting profit sits beneath this price relative to how much debt does. ReNew earns a return on equity of only about 3.5 percent, and its trailing operating income is a thin sliver against net debt of roughly $7 billion, so the conventional coverage and leverage measures are stretched to the point of being alarming on their face. Building power plants consumes capital years before the cash flow arrives, which is the nature of the business, but it also means the equity is a thin, highly geared claim sitting on top of a very large debt stack. If the cost of that debt rises, or if EBITDA growth stalls, the equity bears the squeeze first and hardest.

The valuation, read honestly, is demanding once the asset-based lens is taken seriously. The asset-based and earnings-power methods read the stock as expensive, because on book value and normalized earnings the business is not yet creating value above its cost of capital, earning a return well below the roughly 9 percent that capital costs. On company-wide operating income the price implies growth held at the self-funding ceiling for years, a pace only about a third of comparable fast-growers have sustained. The bull leans on EBITDA and capacity; the bear points out that EBITDA is not free cash flow when a company is plowing every rupee back into new plants and servicing a heavy debt load, and that the gap between reported EBITDA and what reaches equity holders is exactly where capital-intensive growth stories disappoint.

The operating risks are real and largely external. Management itself has flagged grid-expansion delays, project curtailments, and demand-side regulations as ongoing risks, all of which can strand or slow the very capacity the thesis depends on; a plant that cannot evacuate its power to the grid earns nothing while still carrying its debt. India's renewable build-out is also competitive and policy-sensitive, with tariffs set in auctions that can compress returns. Layer the leverage, the sub-cost-of-capital return, the dependence on continued capital access, and the regulatory and grid risks, and the price asks the buyer to underwrite a long, clean, debt-funded expansion in an emerging market, with little accounting earnings to cushion a misstep.

Valuation

ReNew is a capital-intensive renewable power producer, and the right lens is the cash flow and EBITDA of its generating fleet, not its accounting operating income. On that operating-income basis the price looks extreme, implying growth held at the self-funding ceiling for years, but that is partly an artifact of how much depreciation and interest a young, fast-growing asset base carries; the more telling measures are the 12.8 GW of operating capacity and the roughly ₹75 billion of adjusted EBITDA that grew 31 percent in the latest year.

The methods split exactly as they do for a leveraged infrastructure builder. The asset-based and earnings-power methods read the price as expensive, because the business earns a return on equity around 3.5 percent, below its cost of capital on current book economics. The relative-multiple and forward-growth methods reach the price, crediting the capacity growth and the EBITDA trajectory, and a free-cash-flow lens reads the stock as inexpensive on the cash the fleet generates. The disagreement is the whole question: value ReNew on what it earns today and it looks rich; value it on the contracted cash flow of a growing asset base and it looks cheap.

Solvency is where the caution must live, and it is not optional for this name. Net debt is roughly $7 billion against thin trailing operating income, so the conventional coverage ratios are deeply stretched, and the equity is a geared claim on the spread between rising EBITDA and a heavy interest bill. The mitigant the company points to is that leverage is declining even as capacity grows, and EBITDA is rising faster than debt; the risk is that any interruption to that trajectory, from grid delays, curtailment, or higher funding costs, falls on the equity first. The price is underwriting that the EBITDA-up, leverage-down path continues long enough for the contracted cash flows to validate the asset base.

Catalysts

Fiscal 2026 was a record year for the operating business. ReNew reported revenue of roughly ₹132.2 billion, up 36 percent year over year, net income of about ₹10.4 billion, up 162 percent, and adjusted EBITDA of roughly ₹74.8 billion, up 31 percent and above prior guidance. The operating portfolio grew 25 percent to 12.8 GW, with 2.4 GW of new capacity commissioned during the year.

The forward catalysts are capacity, manufacturing, and deleveraging. The company plans to add about 4 GW of solar-cell manufacturing capacity by December 2026, moving upstream in the value chain, and management raised its EBITDA projection for the next fiscal year while targeting further leverage reduction. Management also flagged ongoing risks from grid-expansion delays, project curtailments, and demand-side regulations. The signals to track are the pace of profitable capacity commissioning, progress on the manufacturing ramp, and continued reduction in net debt-to-EBITDA, the three measures that determine whether the contracted cash flows grow into the debt the equity sits above.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

ReNew Energy Global FY2026 results · ReNew Energy Global FY2026 results / earnings call · ReNew Energy Global FY2026 earnings call

View the full interactive RNW report on boothcheck